Terapia innovadora con células madres para formas progresivas de esclerosis múltiple

Results from the first clinical trial using neural stem cells to treat people with MS

Terapia con células madres para EM

It is important for people with MS to have the best available information on stem cell therapy to make decisions related to this complex issue.

Desafíos a los que se enfrentan las investigaciones en EM

Thousands of scientists are undertaking research into all aspects of MS, furthering our understanding of the disease and how to prevent, treat and manage it.

Terapia con células madres mesenquimales para EM: resultados del ensayo internacional

Global trial of mesenchymal stem cell therapy showed no reduction in inflammation for people with active MS

Clinical research and trials

Research and clinical trials are taking place around the world, trying to find and improve treatments for MS

Publicación de resultados de ensayos provisionales de AHSCT

Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other MS therapies have been presented at a Lisbon conference.

Resultados a largo plazo tras un AHSCT en la EM

International study looks at long-term progression in people with MS following stem cell therapy

Stem cell treatment in the news

Autologous Haematopoietic Stem Cell Transplantation (AHSCT) is being investigated as a treatment for MS

El tratamiento de células madre detiene la progresión de la EM

Rebooting immune system provides long term relief for aggressive relapsing MS in Canadian study

Las células madre hematopoyéticas y la EM

The results of a multi-centre, phase II, randomized trial

Un ensayo canadiense relacionado con la terapia con células madre

The Mesenchymal Stem Cell Therapy for Canadian MS Patients Study is part of a larger international research effort

El tratamiento con células madre hematopoyéticas en la EM

Study shows improvement in neurological disability and other clinical outcomes